Wall Street Journal - June 20, 2007
Beckey Bright, beckey.bright@wsj.com
Sixty-one percent of U.S. adults believe poorer countries should be allowed to break companies' patents on HIV/AIDS drugs if doing so would help them treat more of their population, according to a new poll.
When asked specifically about a recent move by Brazil to break the patent on an AIDS drug made by Merck & Co. and provide a generic version instead, 57% said they were in favor of the country's decision, while 20% said they were opposed, the Wall Street Journal Online/Harris Interactive health-care poll found.
Thirty-three percent of those polled said they believe that ignoring companies' patents on HIV/AIDS drugs hinders the development of new drugs, while 40% said they disagree. The poll of 2,246 adults was conducted online June 11-13.
Three-quarters of respondents said programs that teach about and distribute condoms will be most effective in preventing the spread of HIV/AIDS. But half said they agree that the best way to prevent the spread of HIV/AIDS is through programs that teach abstinence.
Forty percent of Americans think the global HIV/AIDS epidemic has worsened in the last five years, down from 58% who said they felt that way when asked the same question in 2004. In the latest poll, 16% said they felt conditions have gotten better, while 32% said things have stayed about the same.
See full results of the poll:
"Based on what you know or have heard, do you think the global HIV/AIDS epidemic has gotten better, worse or stayed about same compared with five years ago?"
Base: All adults
| 2004 | 2007 | |
| Gotten better | 8% | 16% |
| Gotten worse | 58 | 40 |
| Stayed about the same | 24 | 32 |
| Not sure | 10 | 12 |
***
"U.S. spending for the global prevention and treatment of HIV/AIDS focuses on four areas: prevention; treatment; end-of-life care for AIDS patients, and children who have been orphaned by the disease. If you were in charge and you had $100 dollars to distribute between these programs, how would you spend them?"
Base: All adults
| Portion of $100 That Would Spend On(Mean) | ||
| 2004 | 2007 | |
| Prevention | 34.5% | 36.9% |
| Treatment | 23.8 | 23.4 |
| End-of-life care for AIDS patients | 14.3 | 13.6 |
| Children who have been orphaned by the disease | 27.4 | 26.1 |
***
"To what extent do you agree or disagree with each of the following statements?"
Base: All adults
| Agree strongly/ Somewhat (NET) | Agree Strongly | Agree Somewhat | Disagree strongly/ Somewhat (NET) | Disagree Somewhat | Disagree Strongly | Not Sure | |
| Poorer countries should be allowed to break drug patents for HIV/AIDS drugs if it helps them treat more of their population. | 61% | 29% | 32% | 20% | 12% | 8% | 19% |
| When poorer countries break drug patents for HIV/AIDS drugs they hinder the development of new drugs. | 33 | 8 | 25 | 40 | 26 | 14 | 27 |
| The best way to prevent the spread of HIV/AIDS is through programs that teach abstinence. | 51 | 25 | 26 | 42 | 20 | 22 | 7 |
| Abstinence programs hinder, rather than help, efforts to fight HIV/AIDS. | 38 | 14 | 23 | 50 | 28 | 23 | 12 |
| Prevention programs that teach about and distribute condoms will be most effective at preventing the spread of HIV/ AIDS. | 76 | 38 | 38 | 17 | 11 | 6 | 8 |
***
"Brazil recently announced that they will break the patent of an HIV/AIDS drug and purchase a generic version against the wishes of the drug's patent holder. Do you favor or oppose Brazil's decision?"
Base: All adults
| Total | |
| Strongly/Somewhat favor (NET) | 57% |
| Strongly favor | 23 |
| Somewhat favor | 34 |
| Strongly/Somewhat oppose (NET) | 20 |
| Somewhat oppose | 13 |
| Strongly oppose | 7 |
| Not sure | 23 |
Methodology:
Harris Interactive conducted this survey by telephone in the U.S., June 12-13, 2007, among a nationwide cross section of 2,246 adults. Figures for age, gender, race/ethnicity, education, income and region were weighted where necessary to align with population proportions. In theory, with probability samples of this size, one can say with 95% certainty that the overall results have a sampling error of +/- 3.5 percentage points of what they would be if the entire U.S. adult population had been polled with complete accuracy.
070620
WJ070605
Copyright © 2007 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .